- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.1: 29 residues within 4Å:- Chain A: G.14, I.15, I.16, S.20, I.21, A.22, F.41, L.63, D.64, V.65, Q.66, S.94, I.95, G.96, F.97, I.122, M.147, D.148, F.149, Y.158, M.161, K.165, A.191, G.192, P.193, I.194, T.196, M.199
- Ligands: 744.2
20 PLIP interactions:20 interactions with chain A- Hydrophobic interactions: A:I.21, A:F.149, A:A.191
- Hydrogen bonds: A:G.14, A:S.20, A:I.21, A:D.64, A:V.65, A:I.95, A:G.96, A:K.165, A:I.194, A:I.194
- Water bridges: A:A.22, A:F.41, A:S.94, A:I.95, A:T.196, A:T.196
- pi-Stacking: A:F.41
NAD.3: 29 residues within 4Å:- Chain B: G.14, I.15, I.16, S.20, I.21, A.22, F.41, L.63, D.64, V.65, Q.66, S.94, I.95, G.96, F.97, I.122, M.147, D.148, F.149, Y.158, M.161, K.165, A.191, G.192, P.193, I.194, T.196, M.199
- Ligands: 744.4
20 PLIP interactions:20 interactions with chain B- Hydrophobic interactions: B:I.21, B:F.149, B:A.191
- Hydrogen bonds: B:G.14, B:S.20, B:I.21, B:D.64, B:V.65, B:I.95, B:G.96, B:K.165, B:I.194, B:I.194
- Water bridges: B:A.22, B:F.41, B:S.94, B:I.95, B:T.196, B:T.196
- pi-Stacking: B:F.41
NAD.5: 29 residues within 4Å:- Chain C: G.14, I.15, I.16, S.20, I.21, A.22, F.41, L.63, D.64, V.65, Q.66, S.94, I.95, G.96, F.97, I.122, M.147, D.148, F.149, Y.158, M.161, K.165, A.191, G.192, P.193, I.194, T.196, M.199
- Ligands: 744.6
21 PLIP interactions:21 interactions with chain C- Hydrophobic interactions: C:I.21, C:F.149, C:A.191
- Hydrogen bonds: C:G.14, C:S.20, C:I.21, C:D.64, C:D.64, C:V.65, C:I.95, C:G.96, C:K.165, C:I.194, C:I.194
- Water bridges: C:A.22, C:F.41, C:S.94, C:I.95, C:T.196, C:T.196
- pi-Stacking: C:F.41
NAD.7: 29 residues within 4Å:- Chain D: G.14, I.15, I.16, S.20, I.21, A.22, F.41, L.63, D.64, V.65, Q.66, S.94, I.95, G.96, F.97, I.122, M.147, D.148, F.149, Y.158, M.161, K.165, A.191, G.192, P.193, I.194, T.196, M.199
- Ligands: 744.8
21 PLIP interactions:21 interactions with chain D- Hydrophobic interactions: D:I.21, D:F.149, D:A.191
- Hydrogen bonds: D:G.14, D:S.20, D:I.21, D:D.64, D:D.64, D:V.65, D:I.95, D:G.96, D:K.165, D:I.194, D:I.194
- Water bridges: D:A.22, D:F.41, D:S.94, D:I.95, D:T.196, D:T.196
- pi-Stacking: D:F.41
- 4 x 744: (3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE(Non-covalent)
744.2: 20 residues within 4Å:- Chain A: G.96, F.97, M.98, M.103, G.104, F.149, M.155, P.156, A.157, Y.158, M.161, K.165, P.193, T.196, M.199, I.202, L.207, I.215, L.218
- Ligands: NAD.1
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:F.149, A:A.157, A:Y.158, A:Y.158, A:Y.158, A:I.215, A:I.215, A:L.218
- Hydrogen bonds: A:Y.158
744.4: 20 residues within 4Å:- Chain B: G.96, F.97, M.98, M.103, G.104, F.149, M.155, P.156, A.157, Y.158, M.161, K.165, P.193, T.196, M.199, I.202, L.207, I.215, L.218
- Ligands: NAD.3
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:F.149, B:A.157, B:Y.158, B:Y.158, B:Y.158, B:I.215, B:I.215, B:L.218
- Hydrogen bonds: B:Y.158
744.6: 20 residues within 4Å:- Chain C: G.96, F.97, M.98, M.103, G.104, F.149, M.155, P.156, A.157, Y.158, M.161, K.165, P.193, T.196, M.199, I.202, L.207, I.215, L.218
- Ligands: NAD.5
9 PLIP interactions:9 interactions with chain C- Hydrophobic interactions: C:F.149, C:A.157, C:Y.158, C:Y.158, C:Y.158, C:I.215, C:I.215, C:L.218
- Hydrogen bonds: C:Y.158
744.8: 20 residues within 4Å:- Chain D: G.96, F.97, M.98, M.103, G.104, F.149, M.155, P.156, A.157, Y.158, M.161, K.165, P.193, T.196, M.199, I.202, L.207, I.215, L.218
- Ligands: NAD.7
9 PLIP interactions:9 interactions with chain D- Hydrophobic interactions: D:F.149, D:A.157, D:Y.158, D:Y.158, D:Y.158, D:I.215, D:I.215, D:L.218
- Hydrogen bonds: D:Y.158
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- He, X. et al., Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis. J. Med. Chem. (2006)
- Release Date
- 2014-07-30
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 4 x 744: (3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- He, X. et al., Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis. J. Med. Chem. (2006)
- Release Date
- 2014-07-30
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A